Le Lézard
Classified in: Health
Subjects: MAT, MRR

United States Condom Market Analysis Report 2023-2028: Vegan Condoms Gain Traction, Rapid Increase in STIs, and Female Demand Drives Significant Growth


DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "United States Condom Market Competition Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

United States Condom Market is projected to reach a value of $723 million by 2028 from $412 million in 2022, growing at a CAGR of 10.2%

United States Condom market is witnessing high demand owing to the various government initiatives introduced by the government regarding sex education and sexually transmitted diseases (STDs). Moreover, the rising demand among females and the presence of a variety of flavored condoms is further contributing to the market growth.

The United States condom market is witnessing high demand and is expected to grow at a significant growth rate during the forecast years. The growth of the market is attributed to the increasing awareness among consumers, the rising number of diseases, and the growing demand among females. Condoms are available for both males and females and are of different materials which majorly include latex condoms and non-latex condoms.

Moreover, various initiatives by the government are also expected to cater the market growth. For instance, the US Department of Health & Human Services had adopted a strategy namely the National HIV/AIDS Strategy (2022-2025), the strategy sets bold targets for ending the HIV epidemic in the United States by 2030, including a 75% reduction in new HIV infections by 2025 and a 90% reduction by 2030.

Furthermore, the availability of condoms at different stores such as drug/pharmacy stores, convenience stores, departmental stores, and various online portals is also propelling the market growth of the condom market in the United States.

United States Condom Market Drivers

According to the data provided by the national public health agency of the United States namely the Centers for Disease Control and Prevention, sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and other diseases all witnessed a rapid increase between 2020 and 2021 reach to a total of more than 2.5 million reported cases in the united states.

Moreover, according to an article published by the Guardian news, the Syphilis disease had registered 41,700 in 2020 and it rapidly rose to 52,000 in the year 2021. Thus, with the rise in sexually transmitted diseases people have started using condoms as a basic measure to stop the spread of sexually transmitted diseases, which is further contributing to the market growth of the condom market in the United States.

The various initiatives by the government such as the New York State Condom Program announced a partnership with the New York City Condom Program which decided to offer condoms and other safer sex items to New York City-based organizations. Thus, this partnership increased the number of New Yorkers that had access to safer sex supplies and also promote safe sex initiatives in the country.

In 2022, the US Food and Drug Administration (FDA) approved the first condoms specifically designed to reduce STI transmission during anal intercourse, as the risk of STI transmission is significantly higher during anal intercourse than vaginal intercourse.

United States Condom Market Trends

Non-latex condoms offer an alternative to traditional latex condoms for those with latex allergies. These condoms are manufactured from materials such as polyisoprene and polyurethane and are praised for their improved sensation and comfort over traditional latex condoms. In contrast, traditional latex condoms may cause discomfort, irritation, or allergic reactions for those who are allergic to latex.

The primary materials used in these condoms are polyurethane (polyurethane) and polyisoprenes (polyisoprene), with polyurethane condoms being thinner and less elastic in comparison to latex. Polyisoprene condoms, on the other hand, are flexible and have a similar feel to latex. Additionally, some users may not like the latex smell present in traditional condoms and prefer non-latex ones.

Furthermore, vegan condoms are made without the use of any animal-derived materials and neither includes testing, making them suitable for individuals who follow a vegan lifestyle and seek cruelty-free products. Moreover, many of the brands in the United States condom market are launching vegan condoms to enhance their sales and gain a share in the market. For instance, in November 2022, Hanx entered the United States market and launched natural sexual wellness products, which included vegan condoms.

United States Condom Market Challenges

According to the "Family Planning Annual Report 2021" published by the Office of Population Affairs which comes under the United States Department of Health & Human Services reported that condom use as a contraceptive tool went down from 75% in 2011 to 42% among men in 2021. Further, it was reported that the leading contraceptive methods used by females under 15 and 39 years were injectables and pills.

Moreover, according to the article by the Washington Post, the percentage of high schoolers who had used a condom the last time they had sex declined from 63 percent in 2003 to 54 percent in 2019. Thus, this declining trend of usage of condoms as a contraceptive is restraining the growth of the condom market in the United States.

The majority of the companies in the condom market in the United States are providing latex condoms which are allergic to some specific consumers who are sensitive to latex. Thus, the presence of latex in condoms can hinder market growth.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States condom market.

Market Dynamics

Drivers

Market Trends & Developments

Challenges

Voice of Customer Analysis

Report Scope:

United States Condom Market, By Gender:

United States Condom Market, By Type:

United States Condom Market, By Type:

United States Condom Market, By Region:

For more information about this report visit https://www.researchandmarkets.com/r/mcd78x

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: